MNPR·61023L207·US·equity·Healthcare - Biotechnology-Activist
MNPR (MONOPAR THERAPEUTICS INC) is held by 52 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($72.1M), RA CAPITAL MANAGEMENT, L.P. ($36.6M), BlackRock, Inc. ($17.3M). Net institutional sentiment: Mixed.
See how MNPR's score breaks down across 4 SEC sources
Showing 1-20 of 59
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer